Chitosan microparticles loaded with exotoxin A subunit antigen for intranasal vaccination against Pseudomonas aeruginosa: An in vitro study

被引:29
作者
Taranejoo, Shahrouz [2 ]
Janmaleki, Mohsen [2 ]
Rafienia, Mohammad [1 ]
Kamali, Mahdi [3 ]
Mansouri, Maysam [3 ]
机构
[1] Isfahan Univ Med Sci, Biosensor Res Ctr, Sch Med, Med Phys & BioMed Engn Dept, Esfahan 81744176, Iran
[2] Shahid Beheshti Univ MC, Taleghani Hosp, Nanomed & Tissue Engn Res Ctr, Tehran 1985717443, Iran
[3] Baghiatallah Univ Med Sci, Nanobiotechnol Res Ctr, Tehran 1435916471, Iran
关键词
Chitosan; Microparticles; Spray drying; Catalytic domain of exotoxin A (PEIII); Pseudomonas aeruginosa; NASAL DRUG-DELIVERY; MUCOSAL VACCINATION; CONTROLLED-RELEASE; MICROSPHERES; EMULSIFICATION; RELEVANCE; RESPONSES; ANTIBODY; IMMUNITY; POLYMER;
D O I
10.1016/j.carbpol.2010.10.051
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Chitosan microparticles (CMs) were prepared with tripolyphosphate by spray-drying. Effects of polymer molecular weight, sonication power, cross-linking time and concentration of TPP on release profiles of catalytic or third domain pseudomonas exotoxin A (PEIII) and morphology of CMs were evaluated. The mean particle sizes of CMs were in the range from 1.09-1.46 mu m and antigen loading efficiencies were more than 59%. As the molecular weight of chitosan increased, microparticles had a more spherical shape and a smooth surface. An increase in sonication power and decrease in cross-linking time resulted microparticles morphology changes. Approximately 60-80% of PEIII released from microparticles within the first few hours. The release of antigen is increased significantly by raising the sonication power more than 45 W. When the cross-linking time extended from 15 to 60 min, the release of PEIII significantly reduced. The release of PEIII from the microparticles increased when concentration of TPP was raised. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1854 / 1861
页数:8
相关论文
共 47 条
[1]   Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery [J].
Alpar, HO ;
Somavarapu, S ;
Atuah, KN ;
Bramwell, V .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) :411-430
[2]   N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[3]   Mucosal vaccination against bacterial respiratory infections [J].
Baumann, Ulrich .
EXPERT REVIEW OF VACCINES, 2008, 7 (08) :1257-1276
[4]  
Calis S., 1998, 5 EUR S CONTR DRUG D
[5]  
CPMP, 1997, NOT GUID HORM REQ IN
[6]   Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery [J].
Csaba, Noemi ;
Koeping-Hoeggard, Magnus ;
Jose Alonso, Maria .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) :205-214
[7]   Mucosal immunity and tolerance: relevance to vaccine development [J].
Czerkinsky, C ;
Anjuere, F ;
McGhee, JR ;
George-Chandy, A ;
Holmgren, J ;
Kieny, MP ;
Fujiyashi, K ;
Mestecky, JF ;
Pierrefite-Carle, V ;
Rask, C ;
Sun, JB .
IMMUNOLOGICAL REVIEWS, 1999, 170 :197-222
[8]   Diagnosis of neuroparacoccidioidomycosis by detection of circulating antigen and antibody in cerebrospinal fluid [J].
da Silva, SHM ;
Colombo, AL ;
Blotta, MHSL ;
Queiroz-Telles, F ;
Lopes, JD ;
de Camargo, ZP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4680-4683
[9]   Vaccines and immunotherapy against Pseudomonas aeruginosa [J].
Doering, Gerd ;
Pier, Gerald B. .
VACCINE, 2008, 26 (08) :1011-1024
[10]   ABSORPTION OF POLYETHYLENE GLYCOL-600 THROUGH POLYETHYLENE GLYCOL-2000 - THE MOLECULAR-WEIGHT DEPENDENCE OF GASTROINTESTINAL AND NASAL ABSORPTION [J].
DONOVAN, MD ;
FLYNN, GL ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1990, 7 (08) :863-868